Group 1 - A total of 1112 A-share listed companies have invested approximately 839.98 billion yuan in 13,300 financial products this year, marking a year-on-year decline of 14.32% [1] - Major types of financial products purchased by listed companies include time deposits, structured deposits, notice deposits, bank wealth management products, and securities firm wealth management products [1] - Listed insurance companies such as China Life and Xinhua Insurance have announced significant profit growth for the first three quarters, driven by strong investment returns from the stock market [1][2] Group 2 - Omdia projects that global short video revenue will reach 11 billion USD by 2025, indicating a rapid growth trend in this segment [1] - IBM reported third-quarter revenue of 16.33 billion USD, exceeding market expectations, with free cash flow also surpassing estimates [4] - LiblibAI has completed a 130 million USD Series B financing round, marking the largest public financing in China's AI application sector this year [4] Group 3 - Mumei Biological's sub-brand Chunji has closed its Tmall flagship store as part of a planned operational adjustment, focusing on core business and future growth [5] - Standard Shares announced that its stock will continue to be suspended due to significant matters that may change the company's control [5] - Shareholders of Hengshuo Co. plan to reduce their holdings by up to 3%, citing personal funding needs [5]

Core Viewpoint - Marubi Biotech's subsidiary brand Chunji has recently closed its Tmall flagship store, which the company states is a planned operational adjustment based on the brand's business development needs, reflecting a strategic contraction rather than a hasty decision [1] Group 1 - The closure of the Tmall flagship store is described as a normal operational adjustment that has been planned in advance [1] - Marubi Biotech emphasizes that this decision is part of a strategy to optimize its brand portfolio and allocate resources efficiently [1] - The company intends to focus its advantageous resources on core businesses and future growth areas [1]

Investment Rating - The industry investment rating is "stronger than the market" (预计6个月内，行业指数表现强于沪深300指数5%以上) [63] Core Insights - The beauty industry is currently in a rational development phase, with increasing consumer power and competitiveness of domestic brands, particularly those that can quickly respond to consumer needs [3][59] - The 2025 edition of "All Girls' Offer" features 88 brands and 166 SKUs, with a significant increase in participation from domestic brands, reflecting the rise of domestic products and the pursuit of greater exposure by emerging brands [3][10][59] - The negotiation mechanism for this season's offers is more consumer-friendly, with deeper discounts, new products upgraded without price increases, and combinations that better meet consumer needs [3][59] Summary by Sections Consumer Power and Market Dynamics - Consumer power has significantly increased, indicating a "buyer’s market" in the current beauty industry [3][59] - The 2025 offer introduced a competitive mechanism where consumer votes account for 60% of the total, intensifying brand competition [10][59] Brand Participation and Offer Characteristics - This season's offers include a higher proportion of domestic and mass-market brands, with 32 domestic brands and 20 international brands participating [3][10][59] - The offers are characterized by deeper discounts, new products with no price increases, and simpler, cleaner bundles for returning customers [3][25][59] International and Domestic Brand Competition - International brands are continuously upgrading their products, while domestic brands are enhancing their research capabilities and actively participating in offer negotiations [3][42][45] - Emerging domestic brands are seeking greater exposure and sales growth by participating in the offers [53][59] Investment Recommendations - The report suggests focusing on brands such as 毛戈平, 珀莱雅, 上美股份, 爱美客, 贝泰妮, 润本股份, 巨子生物, and 丸美股份, which are well-positioned in the current market [3][59]

Core Insights - The cosmetics sector experienced a decline of 0.72% on October 22, with LaFang JiaHua leading the drop [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Market Performance - Qingdao Jinwang (002094) saw a closing price of 7.88, with an increase of 2.74% and a trading volume of 561,300 shares, amounting to 450 million yuan [1] - Other notable performers included Kesheng Co. (300856) with a closing price of 13.88, up 1.46%, and Yusong Co. (300132) at 6.52, up 1.40% [1] - LaFang JiaHua (603630) closed at 22.55, down 1.83%, with a trading volume of 39,800 shares and a turnover of 90.79 million yuan [2] Capital Flow - The cosmetics sector experienced a net outflow of 12.29 million yuan from institutional investors and 12.90 million yuan from retail investors, while there was a net inflow of 25.19 million yuan from individual investors [2] - The capital flow for individual stocks showed that Qingdao Jinwang had a net inflow of 30.74 million yuan from institutional investors, while LaFang JiaHua had a net outflow of 7.07 million yuan [3] - Other stocks like Kesheng Co. and Yusong Co. also experienced varying degrees of net inflow and outflow from different investor categories [3]

Core Insights - The cosmetics sector experienced a slight decline of 0.03% on October 21, with Lafang Jiahua leading the drop [1] - The Shanghai Composite Index closed at 3916.33, up 1.36%, while the Shenzhen Component Index closed at 13077.32, up 2.06% [1] Group 1: Stock Performance - Jinsheng New Material (300849) saw a significant increase of 7.74%, closing at 14.76 with a trading volume of 103,000 shares and a turnover of 148 million yuan [1] - Jiaheng Jiahua (300955) rose by 4.90%, closing at 30.62 with a trading volume of 45,700 shares and a turnover of 137 million yuan [1] - Qing Song Co. (300132) increased by 3.71%, closing at 6.43 with a trading volume of 266,600 shares and a turnover of 170 million yuan [1] - Lafang Jiahua (603630) declined by 2.67%, closing at 22.97 with a trading volume of 61,500 shares and a turnover of 141 million yuan [2] - Shanghai Jahwa (600315) fell by 1.85%, closing at 27.09 with a trading volume of 96,400 shares and a turnover of 262 million yuan [2] Group 2: Capital Flow - The cosmetics sector experienced a net outflow of 11.49 million yuan from institutional investors, while retail investors saw a net inflow of 19.36 million yuan [2] - The main capital inflow was observed in brands like Banlaya (603605) with a net inflow of 10.38 million yuan, while Jinsheng New Material (300849) had a net outflow of 11.78 million yuan [3] - Retail investors showed a significant net inflow in Furuida (600223) with 7.23 million yuan, while the outflow from institutional investors was 3.19 million yuan [3]

证券研究报告 行业研究|行业点评研究|商贸零售 受国补边际效应减弱、中秋假期错位等 影响，9 月社零增速放缓 请务必阅读报告末页的重要声明 glzqdatemark1 2025年10月21日 邓文慧 郭家玮 SAC：S0590522060001 SAC：S0590525030001 请务必阅读报告末页的重要声明 1 / 4 证券研究报告 |报告要点 国家统计局发布社零数据，9 月份，社零总额为 4.20 万亿元，同比增长 3.0%。其中，除汽车 以外的消费品零售额为 3.73 万亿元，同比增长 3.2%；限额以上单位消费品零售额 1.78 万亿 元，同比增长 2.3%。 |分析师及联系人 行业研究|行业点评研究 glzqdatemark2 2025年10月21日 商贸零售 受国补边际效应减弱、中秋假期错位等影响， 9 月社零增速放缓 投资建议： 强于大市（维持） 上次建议： 强于大市 相对大盘走势 -10% 7% 23% 40% 2024/10 2025/2 2025/6 2025/10 商贸零售 沪深300 相关报告 1、《商贸零售：7 月社零同比+3.7%，环比有 所回落》2025.08.16 2、《商贸 ...

Core Viewpoint - The beauty brand Chunji under Marubi Biotech is quietly withdrawing from the market, with its flagship store on major e-commerce platforms already closed and no new products launched in over a year [1][2]. Company Overview - Marubi Biotech launched Chunji in 2007, focusing on natural skincare for young women and was once a significant brand within its portfolio [2]. - Chunji's revenue peaked between 2014 and 2016, reaching 170 million yuan, but declined to 142 million yuan by 2018, with its revenue share dropping from 14.11% to 9.06% [2]. - After Marubi Biotech went public in 2019, Chunji's specific revenue data was no longer reported, although it was noted that the brand faced challenges due to increased competition and traditional marketing limitations [2]. Market Dynamics - In contrast to Chunji's decline, Marubi Biotech's makeup brand, Lianhuo, has seen rapid growth since its launch in 2017, with revenues increasing significantly from 66.17 million yuan in 2021 to an expected 1 billion yuan in 2025 [2][3]. - The rise of domestic makeup brands in the context of the "Guochao" trend has contributed to Lianhuo's success, while Chunji struggled to maintain its market position [3]. Strategic Insights - The withdrawal of Chunji is attributed to unclear brand positioning and fluctuating business strategies, leading to a loss of both existing and potential customers [3]. - Experts suggest that for Chunji to succeed, it needs a clearer and more unique positioning and channel strategy, indicating that the brand's traditional operational model may no longer be viable [3].

Core Viewpoint - Natural Hall, a well-known domestic beauty brand, is facing challenges in profitability and research and development, despite its historical significance and market presence [2][4]. Financial Performance - Revenue for Natural Hall from 2022 to 2024 is projected to be 4.292 billion, 4.442 billion, and 4.601 billion yuan, with net profits of 139 million, 302 million, and 190 million yuan respectively [4]. - The compound annual growth rate (CAGR) for revenue from 2022 to 2024 is only 3.5%, significantly lower than the industry average of 6.6% [4]. Revenue Structure - Approximately 90% of Natural Hall's revenue is derived from its core brand, "Natural Hall," indicating a heavy reliance on a single brand [5][6]. - The other four brands under Natural Hall contribute only about 5% of total revenue, highlighting limited market influence [7]. Marketing and R&D Expenditure - Natural Hall maintains a high gross margin, but its net profit margin fluctuates between 3.2% and 7.8%, which is considerably lower than competitors [9]. - Marketing expenses from 2022 to 2024 exceeded 7.5 billion yuan, while R&D investment was only about 348 million yuan, indicating a marketing-to-R&D expenditure ratio of 21.55 times [10][11]. Channel Strategy - Online revenue share increased from 59.7% to 68.8% from 2022 to the first half of 2025, while offline revenue share decreased to around 30% [12]. - Despite the growth in online sales, Natural Hall continues to expand its offline retail presence, with over 62,700 retail terminals as of mid-2025 [13]. Corporate Governance - Natural Hall is a family-controlled business, with the Zheng family holding 87.82% of voting rights, ensuring significant control over strategic decisions [14]. - The company recently brought in strategic investors, including L'Oréal and CVC Capital, while maintaining family control over the board [15]. Market Position and Challenges - The Chinese cosmetics market is projected to grow from 779.4 billion yuan in 2019 to 934.6 billion yuan in 2024, with domestic brands expected to capture over 50% market share by 2025 [16]. - Natural Hall's reliance on celebrity endorsements poses risks, as seen with recent controversies affecting brand reputation [16][17].

Core Viewpoint - The beauty brand Chunji under Marubi Bio is quietly exiting the market, with its flagship store on major e-commerce platforms closed and no new products launched since July 2024 [1][2][3]. Group 1: Brand Performance and Market Presence - Chunji's flagship store on Tmall announced its intention to cease operations by October 26, 2025, and has already removed all product links since August 2023 [1]. - The brand has closed its stores on multiple e-commerce platforms, including JD, Chuchujie, Mogujie, Pinduoduo, and Juanpi, and has not updated its WeChat account since early 2023 [1][2]. - Chunji's last registered product was recorded in July 2024, indicating over a year without new product launches [1]. Group 2: Historical Financial Performance - Chunji was launched in 2007 with a focus on natural skincare for young women, and at its peak, it contributed significantly to Marubi Bio's revenue, with sales rising from 144 million yuan in 2014 to 170 million yuan in 2016, accounting for 14.11% of total revenue [2]. - However, after 2016, Chunji's revenue declined to 142 million yuan by 2018, reducing its market share to 9.06% [2]. - Since Marubi Bio's IPO in 2019, Chunji's specific revenue figures have not been disclosed, but the company acknowledged a decline due to intensified market competition and limitations of traditional marketing [2]. Group 3: Strategic Shift and Market Trends - Marubi Bio's strategic shift from Chunji to its rapidly growing color cosmetics brand, Lianhuo, is evident, with Lianhuo's revenue skyrocketing from 66.17 million yuan in 2021 to an expected 1 billion yuan in 2025 [3]. - The rise of domestic color cosmetics brands, fueled by the "Guochao" trend, has contributed to Lianhuo's success, while Chunji's unclear brand positioning and fluctuating strategies led to a loss of both existing and potential customers [3]. - Industry experts suggest that Chunji's exit may be part of Marubi Bio's plan to explore a new business model, emphasizing the need for clearer brand positioning and channel strategies for future success [3].

Core Viewpoint - The beauty brand Chunji under Marubi Biotechnology is quietly withdrawing from the market, with its flagship store on major e-commerce platforms already closed and no new products launched in over a year [2][3][4]. Group 1: Brand Status - Chunji's flagship store on Tmall announced its intention to cease operations by October 26, 2025, and has removed all product links since August 2023 [2]. - The brand has also closed its stores on other major platforms such as JD, Chuchujie, and Pinduoduo, and has not updated its WeChat or Weibo accounts since early 2023 and May 2022, respectively [2][3]. - The last product registered for Chunji was in July 2024, indicating no new product launches in over a year [2]. Group 2: Financial Performance - Chunji was launched in 2007 with a focus on natural skincare for young women, and at one point contributed significantly to Marubi's revenue, with sales rising from 144 million yuan in 2014 to 170 million yuan in 2016, accounting for 14.11% of Marubi's revenue [3][4]. - However, after 2016, Chunji's revenue declined to 142 million yuan by 2018, with its revenue share dropping to 9.06% [4]. - Following Marubi's IPO in 2019, Chunji's specific revenue figures were no longer disclosed, although it was noted that the brand faced challenges due to increased competition and limitations of traditional marketing [4]. Group 3: Strategic Shift - In contrast to Chunji's decline, Marubi's color cosmetics brand, Lianhuo, has seen rapid growth, with revenues increasing from 66.17 million yuan in 2021 to an expected 1 billion yuan in 2025 [4]. - The strategic shift from Chunji to Lianhuo aligns with the rise of domestic color cosmetics brands and changing consumer preferences [4]. Group 4: Expert Opinion - Industry experts suggest that Chunji's withdrawal is primarily due to unclear brand positioning and fluctuating business strategies, leading to a loss of both existing and potential customers [5]. - There is speculation that Marubi may be planning a new model for Chunji, but without a clear departure from traditional operations, the brand's challenges are likely to persist [5].